Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismaheel Lawal

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
American Journal of Nuclear Medicine and Molecular Imaging|May 25, 2026
Bladder activity of different PSMA PET radioligands and impact of furosemideIsmaheel Lawal, Aliza Mushtaq, Samuel N Gitau, et al.
Nuklearmedizin. Nuclear Medicine|April 14, 2022
The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/mlThabo Lengana, Ismaheel Lawal, Charl Janse Van Rensburg, et al.
Journal of Clinical Medicine|January 21, 2023
The SARS-COV-2 Seroprevalence among Oncology PatientsMankgopo Kgatle, Rajesh Das, Ismaheel Lawal, et al.
European Urology|December 18, 2025
[<sup>18</sup>F]-Fluciclovine or [<sup>68</sup>Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 TrialAshesh B Jani, Vishal R Dhere, Subir Goyal, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
American Journal of Nuclear Medicine and Molecular Imaging|May 25, 2026
Bladder activity of different PSMA PET radioligands and impact of furosemideIsmaheel Lawal, Aliza Mushtaq, Samuel N Gitau, et al.
Nuklearmedizin. Nuclear Medicine|April 14, 2022
The Diagnostic Performance of 18F-PSMA-1007 PET/CT in Prostate Cancer Patients with Early Recurrence after Definitive Therapy with a PSA <10 ng/mlThabo Lengana, Ismaheel Lawal, Charl Janse Van Rensburg, et al.
Journal of Clinical Medicine|January 21, 2023
The SARS-COV-2 Seroprevalence among Oncology PatientsMankgopo Kgatle, Rajesh Das, Ismaheel Lawal, et al.
European Urology|December 18, 2025
[<sup>18</sup>F]-Fluciclovine or [<sup>68</sup>Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 TrialAshesh B Jani, Vishal R Dhere, Subir Goyal, et al.
Pageof 3